Success Story: RFE Overcome for an Organic Chemistry Researcher from China in an I-140 EB-1A Case
Client’s Testimonial:
“I am very grateful to North America Immigration Law Group for their professional and experienced support throughout my EB-1A petition, especially in handling the RFE. Their expertise, responsiveness, and attention to detail gave me confidence throughout the process.”
On August 17th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: August 17th, 2026
Processing Time: 11 months, 2 days (Premium Processing Upgrade Requested)
Case Summary:
Responding to the RFE with a Focused EB-1A Strategy
Receiving a Request for Evidence (RFE) in an I-140 EB-1A case can make the approval path more demanding, especially when the petition must show not only strong credentials but also sustained acclaim and original contributions of major significance. For this organic chemistry researcher from China, North America Immigration Law Group responded by presenting a focused record of peer-reviewed research, independent scholarly reliance, peer-review service, expert support, and evidence that the client’s work had influenced the broader field.
Background and Research Focus
The client holds a Ph.D. in chemistry and, at the time of filing, was conducting advanced organic chemistry research at a U.S. university. The client’s work focuses on developing new chemical methods for building and modifying molecules, with applications relevant to pharmaceuticals and related scientific fields.
Objective Evidence of Extraordinary Ability
To demonstrate the client’s extraordinary ability, the petition presented objective evidence of scholarly productivity, peer recognition, and independent reliance. The client’s record included 8 peer-reviewed journal articles, including 5 first-authored articles, 2 first-authored conference abstracts, 1 U.S. patent publication, at least 35 completed peer reviews, and over 282 citations to several highlighted publications.
The petition also showed that at least 7 of the client’s papers ranked among the most highly cited Chemistry articles for their respective publication years. We further highlighted publication in highly selective scientific venues and research support from major funding sources, such as the National Institute of General Medical Sciences (NIGMS).
Demonstrating Major Significance
The petition demonstrated the client’s significance by showing that independent researchers around the world had relied on the client’s work in studies involving organic synthesis, catalysis, and related areas of chemical research. Rather than relying on numbers alone, we explained how the client’s methods and insights had helped other researchers develop new catalytic platforms and extend synthetic chemistry strategies to additional systems.
Expert Support and Independent Recognition
The case was supported by 3 recommendation letters, all independent advisory opinions. These experts described the client’s contributions to organic chemistry and related scientific research. One expert noted:
“There is thus no doubt that [Client] shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns.”
We also highlighted peer-review invitations from authoritative journals, media coverage of the client’s research, a U.S. patent publication, and evidence of the client’s role in research supported by major funding sources.
The Result
Through the RFE response, we clarified how the client’s publication record, citation impact, peer-review service, expert support, media recognition, patent record, and current U.S.-based research satisfied the EB-1A standard.
Filed on April 13th, 2026, and approved on August 17th, 2026, after a premium processing upgrade, this I-140 EB-1A case concluded in 4 months and 4 days. We congratulate the client on this approval and look forward to the client’s continued contributions to organic chemistry and pharmaceutical research in the United States.